NeuBase Therapeutics Demonstrates Functional Rescue in Myotonic Dystrophy Type 1 Model and Allele-Selective Inhibition of KRAS Mutations to Inhibit Tumor Growth
Stock Information for NeuBase Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.